SOLNA, Sweden--(BUSINESS WIRE)--Regulatory News: Aerocrine AB (STO:AEROB) today announced that its first quarter sales development has been below expectations. Revenues are estimated to reach approximately 18 MSEK compared to 26,9 MSEK previous year.
